![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
Previsioni di mercato delle particelle simili a virus nell\'Asia del Pacifico fino al 2028 - Impatto del COVID-19 e analisi regionale per tipo di prodotto (epatite, cancro/HPV e malattia di Gaucher), fonte (lievito, cellule di insetti, piante e altri) e applicazione (vaccini) e terapeutico)
Si prevede che il mercato delle particelle simili a virus nell\'Asia del Pacifico crescerà da 1.018,83 milioni di dollari nel 2021 a 1.769,02 di dollari milioni entro il 2028;si stima che crescerà a un CAGR dell\'8,2% dal 2021 al 2028.
Diversi attori del mercato sanitario e organizzazioni di ricerca sono attivamente coinvolti nelle innovazioni e nello sviluppo dei prodotti. L’uso di particelle simili a virus è un approccio emergente utilizzato nell’industria biofarmaceutica. Poiché le particelle simili a virus sono prive del contenuto virale, sono più facili da gestire rispetto ai componenti virali effettivi. I VLP possono essere utilizzati per facilitare la somministrazione di farmaci, l\'imaging, l\'immunoterapia e la terapia terapeutica. Ad esempio, secondo uno studio pubblicato dall\'NCBI nel giugno 2020, la VLP può essere utilizzata sotto forma di nanoparticelle in applicazioni quali terapia fototermica, imaging PET e TC, vettori di agenti di contrasto per MRI, imaging ottico, vaccini per malattie infiammatorie e autoimmuni, immunoterapia antitumorale e somministrazione di farmaci a piccole molecole (nella terapia antitumorale). Pertanto, si prevede che tali potenziali applicazioni dei VLP forniranno opportunità di crescita agli operatori del mercato durante il periodo di previsione.Secondo il rapporto del Fondo monetario internazionale (FMI) , si prevedeva che la crescita nell\'Asia Pacifico sarebbe rimasta ferma allo zero% nel 2020. Si è trattato della peggiore performance di crescita in quasi 60 anni che ha coinvolto la crisi finanziaria globale (4,7%) e la crisi finanziaria asiatica (1,3%). Le revisioni al ribasso sono state sostanziali, variando dal 3,5% nel caso della Corea, ma sembrano essere riuscite a gestire la lenta diffusione del coronavirus a causa di interruzioni prolungate della produzione minimizzate che rappresentano il 9% in Australia, Nuova Zelanda e Tailandia. Questi paesi sono stati duramente colpiti dalla chiusura del turismo a livello mondiale e, nel caso dell’Australia, dal calo dei prezzi delle materie prime. L’Asia del Pacifico, dove sono attualmente in fase di sviluppo i vaccini contro il Covid-19, comprende Corea del Sud, Cina, Giappone, Tailandia e Vietnam. Tra questi, la Cina ha 15 vaccini, l’India e la Corea del Sud ne possiedono tre, il Giappone ha due vaccini e la Tailandia e il Vietnam ne hanno uno. Tra questi vaccini figurano dieci vaccini inattivati, sei vaccini a subunità proteica, sette vaccini a vettore virale e sei vaccini a base di acido nucleico. Inoltre, la promozione di un vaccino sicuro, equo ed efficace è una priorità assoluta nella regione dell’Asia del Pacifico. Secondo il rapporto della Banca asiatica di sviluppo, nel dicembre 2020, la Banca asiatica di sviluppo (ADB) ha lanciato un\'iniziativa di vaccini da 9 miliardi di dollari con l\'Asia Pacific Vaccine Access Facility (APVAX) che offrirà un supporto rapido ed equo ai paesi in via di sviluppo paesi (DMC) per procurarsi e fornire un vaccino COVID-19 efficace e sicuro. Attraverso la vaccinazione, è possibile interrompere la catena di trasmissione del virus, salvare vite umane e mitigare l\'impatto negativo della pandemia.
Con il nuovo caratteristiche e tecnologie, i fornitori possono attrarre nuovi clienti ed espandere la propria presenza nei mercati emergenti. È probabile che questo fattore guidi il mercato delle particelle simili ai virus nell’Asia del Pacifico. Si prevede che il mercato delle particelle simili a virus nell\'Asia del Pacifico crescerà a un buon CAGR durante il periodo di previsione.
Entrate e previsioni del mercato delle particelle simili a virus nell\'Asia del Pacifico fino al 2028 (milioni di dollari)
Segmentazione del mercato delle particelle simili a virus nell\'Asia del Pacifico
Mercato delle particelle simili a virus nell\'Asia del Pacifico - Per tipo di prodotto
- Epatite
- Cancro/HPV
- Malattia di Gaucher
Mercato delle particelle simili a virus nell\'Asia del Pacifico - Per fonte
- Lievito
- Cellula di insetto
- Impianti
- Altri
Mercato delle particelle simili a virus nell\'Asia del Pacifico: – Per applicazione
- Vaccini
- Terapeutici
Mercato delle particelle simili a virus nell\'Asia del Pacifico - Per Paese
- Cina
- Giappone
- India
- Australia
- Corea del Sud
- Resto dell\'Asia Pacifico
Mercato delle particelle simili a virus nell\'Asia Pacifico - Aziende citate
- Merck & Co., Inc. ; \' bsp ;
- GlaxoSmithKline plc.
- Pfizer Inc.  ; \' bsp ; ;
- Sanofi ; ;
- < span>Serum Institute of India Pvt. Ltd.
- BHARAT BIOTECH   ; \' bsp ;
- LG Chem ; ;
- Wantai BioPharm
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Virus-like Particles Market – By Product Type
1.3.2 Asia Pacific Virus-like Particles Market – By Source
1.3.3 Asia Pacific Virus-like Particles Market – By Application
1.3.4 Asia Pacific Virus-like Particles Market – By Country
2. Asia Pacific Virus-like Particles Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Virus-like Particles Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Experts Opinion
5. Asia Pacific Virus-like Particles Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Surging Prevalence of Infectious Viral Diseases
5.1.2 Increasing Role of Virus-Like Particles in Therapeutic Developments and Studies
5.2 Market Restraints
5.2.1 Reach of Alternative Technologies for Viral Vaccine Production
5.3 Market Opportunities
5.3.1 Growing Potential Applications in Therapeutics and Diagnostics
5.4 Future Trends
5.4.1 Steady Demand for Innovative and Effective Products
5.5 Impact Analysis
6. Asia Pacific Virus-like Particles Market Analysis
6.1 Asia Pacific Virus-like Particles Market Revenue Forecast and Analysis
7. Asia Pacific Virus-like Particles Market Analysis – by Product Type
7.1 Overview
7.2 Asia Pacific Virus-like Particles Market, by Product Type, 2021 & 2028 (%)
7.3 Hepatitis
7.3.1 Overview
7.3.2 Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
7.4 Cancer/ Human Papillomavirus (HPV)
7.4.1 Overview
7.4.2 Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
7.5 Gaucher Disease
7.5.1 Overview
7.5.2 Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
8. Asia Pacific Virus-like Particles Market Analysis – By Source
8.1 Overview
8.2 Asia Pacific Virus-like Particles Market Share, by Source, 2021 & 2028 (%)
8.3 Yeast
8.3.1 Overview
8.3.2 Yeast: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
8.4 Plant
8.4.1 Overview
8.4.2 Plant: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
8.5 Insect Cell
8.5.1 Overview
8.5.2 Insect Cell: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
9. Asia Pacific Virus-like Particles Market Analysis – By Application
9.1 Overview
9.2 Asia Pacific Virus-like Particles Market Share, by Application, 2021 & 2028 (%)
9.3 Vaccines
9.3.1 Overview
9.3.2 Vaccine: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
9.4 Therapeutics
9.4.1 Overview
9.4.2 Therapeutics: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10. Asia Pacific Virus-like Particles Market – Country Analysis
10.1 Overview
10.1.1 Asia Pacific: Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)
10.1.1.1 Japan: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Japan: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Product Type (US$ Million)
10.1.1.1.4 Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)
10.1.1.1.5 Japan Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.2 China: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 China: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.4 China: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)
10.1.1.2.5 China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.3 India Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 India: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.4 India Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.5 India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.4 South Korea: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 South Korea: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3 South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.4 South Korea Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.5 South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.5 Australia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 Australia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.3 Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.4 Australia Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.5 Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.6 Rest of Asia Pacific: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Asia Pacific: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.3 Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.4 Rest of Asia Pacific Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.5 Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
11. Impact Of COVID-19 Pandemic on Asia Pacific Virus-like Particles Market
11.1 Impact Assessment of COVID-19 Pandemic
12. Asia Pacific Virus-like Particles Market–Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Merck & Co., Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 GlaxoSmithKline plc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Pfizer Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Sanofi
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Wantai BioPharm
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Serum Institute of India Pvt. Ltd.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 BHARAT BIOTECH
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 LG Chem
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific Virus-like Particles Market, Revenue and Forecast to 2028 (US$ Million)
Table 2. Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Product Type (US$ Million)
Table 3. Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)
Table 4. Japan Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 5. China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 6. China: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)
Table 7. China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 8. India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 9. India Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 10. India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 11. South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 12. South Korea Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 13. South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 14. Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 15. Australia Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 16. Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 18. Rest of Asia Pacific Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 19. Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 20. Organic Developments Done by Companies
Table 21. Inorganic Developments Done by Companies
Table 22. Glossary of Terms: Virus-like Particles Market
LIST OF FIGURES
Figure 1. Asia Pacific Virus-like particles Market Segmentation
Figure 2. Asia Pacific Virus-like particles Market Segmentation, By Country
Figure 3. Asia Pacific Virus-like Particles Market Overview
Figure 4. Hepatitis Held the Largest Share of the Product Type Segment in Asia Pacific Virus-like particles Market
Figure 5. India to Show Significant Growth during Forecast Period
Figure 6. Asia Pacific Virus-like Particles Market, Industry Landscape
Figure 7. Asia Pacific PEST Analysis
Figure 8. Asia Pacific Virus-like Particles Market: Impact Analysis of Drivers and Restraints
Figure 9. Asia Pacific Virus-like Particles Market– Revenue Forecast and Analysis to 2028
Figure 10. Asia Pacific Virus-like Particles Market, by Product Type, 2021 & 2028 (%)
Figure 11. Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 12. Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 13. Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 14. Asia Pacific Virus-like Particles Market Share, by Source, 2021 & 2028 (%)
Figure 15. Yeast: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16. Plant: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17. Insect Cell: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. Others: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19. Asia Pacific Virus-like Particles Market Share, by Application, 2021 & 2028 (%)
Figure 20. Vaccine: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. Therapeutics: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. Asia Pacific Virus-like Particles Market Overview, by Country (2021)
Figure 23. Asia Pacific: Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)
Figure 24. Japan: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 25. China: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 26. India: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 27. South Korea: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 28. Australia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 29. Rest of Asia Pacific: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
- Merck & Co., Inc.
- GlaxoSmithKline plc.
- Pfizer Inc.
- Sanofi
- Serum Institute of India Pvt. Ltd.
- BHARAT BIOTECH
- LG Chem
- Wantai BioPharm
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific virus-like particles market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific virus-like particles market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the virus-like particles market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution